VR
Venkat Ram Jagarlamudi
About Venkat Ram Jagarlamudi
Data last updated:
Venkat Ram Jagarlamudi is a Non- Individual Subscriber at Saicriti Pharma Private Limited (since 2026), Director at Ewing Pharma Private Limited (since 2022) and Designated Partner at Vasudaika Realty Llp (since 2021), and holds 3 more current directorships. The companies operate in Chemicals, Real Estate and Construction and Pharma. Earlier, Venkat Ram Jagarlamudi was a Director at Questus Pharma Private Limited (2023–2025) and Director at Prathyak Laboratories Private Limited (2023–2025) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saicriti Pharma Private Limited U21000TS2026PTC218822 | Non- Individual Subscriber | 08 Jul 2026 | 2026 | Active | |
| Ewing Pharma Private Limited U24290TG2022PTC167899 | Director | 01 Nov 2022 | 2022 | Active | |
| Vasudaika Realty Llp AAV-6384 | Designated Partner | 30 Jan 2021 | 2021 | Active | |
| Vasudaika Ventures Llp AAU-8221 | Designated Partner | 25 Nov 2020 | 2020 | Active | |
| Vasudaika Projects Llp AAT-9786 | Designated Partner | 25 Sep 2020 | 2020 | Active | |
| Cbc Projects Llp AAO-7139 | Designated Partner | 30 Mar 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Questus Pharma Private Limited U24239TG2021PTC154020 | Director | 09 Oct 2023 | 2021 | ₹38.87 Cr (FY 2025) | Active |
| Prathyak Laboratories Private Limited U24290TG2022PTC166750 | Director | 09 Oct 2023 | 2022 | ₹7.5 Lakh (FY 2025) | Active |
| Halsted Pharma Private Limited U24290TG2022PTC166288 | Director | 09 Oct 2023 | 2022 | ₹36.78 Cr (FY 2025) | Active |
| Vivint Pharma Private Limited U24299TG2022PTC165671 | Director | 01 Nov 2023 | 2022 | Active | |
| Coley Pharma Private Limited U24299TG2022PTC167815 | Director | 09 Oct 2023 | 2022 | ₹11,000 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Venkat Ram Jagarlamudi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Srilatha Jagarlamudi | 09047049 | Saicriti Pharma Private Limited , Vasudaika Realty Llp and 2 more | Director |
| Mukesh Vijayvargiya | 08153379 | Ewing Pharma Private Limited | Director |
| Swati Shivaji Jagadale | 09778703 | Ewing Pharma Private Limited | Director |
| Prashanth Reddy Tatikonda | 03525307 | Vasudaika Ventures Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkat Ram Jagarlamudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkat Ram Jagarlamudi
Venkat Ram Jagarlamudi currently holds 6 directorships: Saicriti Pharma Private Limited (Non- Individual Subscriber, since 08 Jul 2026); Ewing Pharma Private Limited (Director, since 01 Nov 2022); Vasudaika Realty Llp (Designated Partner, since 30 Jan 2021); Vasudaika Ventures Llp (Designated Partner, since 25 Nov 2020); Vasudaika Projects Llp (Designated Partner, since 25 Sep 2020); and 1 more.
Venkat Ram Jagarlamudi was first appointed on 30 Mar 2019 as Designated Partner at Cbc Projects Llp. The most recent appointment on record is 08 Jul 2026 at Saicriti Pharma Private Limited.
Venkat Ram Jagarlamudi held 5 earlier board appointments: Questus Pharma Private Limited (Director, 09 Oct 2023 to 19 Jun 2025); Prathyak Laboratories Private Limited (Director, 09 Oct 2023 to 19 Jun 2025); Halsted Pharma Private Limited (Director, 09 Oct 2023 to 19 Jun 2025); Vivint Pharma Private Limited (Director, 01 Nov 2023 to 19 Jun 2025); Coley Pharma Private Limited (Director, 09 Oct 2023 to 03 Mar 2025).
The current boards of Venkat Ram Jagarlamudi's companies include Srilatha Jagarlamudi (Saicriti Pharma Private Limited), Mukesh Vijayvargiya (Ewing Pharma Private Limited), Swati Shivaji Jagadale (Ewing Pharma Private Limited), Prashanth Reddy Tatikonda (Vasudaika Ventures Llp).